5,7-diaminopyrazolo[4,3-D]pyrimidines useful in the treatment of hypertension

Details for Australian Patent Application No. 2004234158 (hide)

Owner Pfizer Inc.

Inventors Bell, Andrew Simon; Palmer, Michael John; Marsh, Ian Roger; Fox, David Nathan Abraham; Morrell, Andrew Ian; Brown, David Graham; Winslow, Carol Ann

Agent Spruson & Ferguson

Pub. Number AU-B-2004234158

PCT Pub. Number WO2004/096810

Priority 0309780.5 29.04.03 GB; 0327748.0 28.11.03 GB

Filing date 22 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 28 January 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/096810 Priority application(s): WO2004/096810

27 October 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read 5,7-diaminopyrazolo[4,3-D]pyrimidines useful in the treatment of hypertension

28 January 2010 Application Accepted

  Published as AU-B-2004234158

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234176-Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

2004234142-Method for producing a water soluble package